Publication | Closed Access

Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D

VaccinationMucosal VaccinationVaccine DevelopmentImmunologyTuberculosisMicrobiologyInfection ControlVaccine DesignMedicineVaccine ResearchInactive Form